Heart block also termed as atrioventricular (AV) block refers to a condition, in which the electric signals that regulate the heartbeat are moderately or absolutely blocked from reaching the ventricles. On the basis of criticality, heart blocks can be classified into three degrees. First degree heart block involves partially slowed electric signals while passing from atria to ventricle. This stage does not causes much significant symptoms hence do not require treatment. Second degree heart block involves significantly slowed electric signals from atria to ventricle. This affects the proper working of heart. This type of condition is more common in people suffering from certain heart diseases; for instance heart failure. Third degree heart blocks result in complete blockage of signals from passing from atria to ventricle. Condition in which heart block is present in a person right from the birth, due to some defect or genetic condition, is termed as congenital heart block. Heart block may also be caused by some other conditions such as heart attack, some infections such as diphtheria, medicinal reactions and others. Various devices that can be used to treat heart blocks include pacemaker, which uses electric signals to regulate heart beat at a standard rate.
In 2019, the market size of Heart Blocks Treatment Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Heart Blocks Treatment Devices.
This report studies the global market size of Heart Blocks Treatment Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Heart Blocks Treatment Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Boston Scientific Corporation
St. Jude Medical, Inc.
BIOTRONIK SE & Co. KG
Market Segment by Product Type
Sinoatrial node (SA node) nodal block
Atrioventricular node (AV node) nodal block
Market Segment by Application
Key Regions split in this report: breakdown data for each region.
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Heart Blocks Treatment Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Heart Blocks Treatment Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Heart Blocks Treatment Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025